Alavita Pharmaceuticals, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 2005-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://alavita.lu
Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)Phase 2 Study of the Safety of Diannexin in Kidney Transplant Recipients
- First Posted Date
- 2008-02-14
- Last Posted Date
- 2011-06-29
- Lead Sponsor
- Alavita Pharmaceuticals Inc
- Target Recruit Count
- 58
- Registration Number
- NCT00615966
- Locations
- 🇺🇸
University of Maryland, Baltimore, Maryland, United States
🇺🇸St Barnabas Medical Center, Livingston, New Jersey, United States
🇺🇸New York-Presbyterian Hospital/Weill Cornell Medical Center, New York, New York, United States
News
No news found